|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 134.28 USD | -1.48% |
|
+3.43% | +9.40% |
| Jul. 16 | Kalshi to allow bets on clinical trials, FDA decisions | RE |
| Jul. 15 | African markets - factors to watch on July 15 | RE |
| Market Cap | 167B 146B 135B 124B 234B 16,050B 239B 1,607B 632B 7,847B 626B 612B 27,092B | P/E 2026 * |
-48.4x | P/E 2027 * | 17x |
|---|---|---|---|---|---|
| Enterprise Value | 176B 154B 142B 131B 247B 16,961B 253B 1,698B 668B 8,292B 662B 647B 28,629B | EV / Sales 2026 * |
5.78x | EV / Sales 2027 * | 5.15x |
| Free-Float |
99.88% | Yield 2026 * |
2.42% | Yield 2027 * | 2.5% |
Last Transcript: Gilead Sciences, Inc.
| 1 day | -1.48% | ||
| 1 week | +3.43% | ||
| Current month | +6.28% | ||
| 1 month | +8.50% | ||
| 3 months | -2.44% | ||
| 6 months | +7.50% | ||
| Current year | +9.40% |
| 1 week | 127.94 |  | 140.61 |
| 1 month | 123 | | 140.61 |
| Current year | 116.88 | | 157.29 |
| 1 year | 107.75 | | 157.29 |
| 3 years | 62.07 | | 157.29 |
| 5 years | 57.16 | | 157.29 |
| 10 years | 56.56 | | 157.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 2019-02-28 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 2019-10-31 |
Keeley Wettan
CMP | Compliance Officer | - | 2025-12-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 2016-08-18 |
| Director/Board Member | 73 | 2017-12-31 | |
Harish Manwani
BRD | Director/Board Member | 72 | 2018-05-08 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/15/26 | Sell | Chief Financial Officer | -3,000 | 0.0002% | ||
| 7/15/26 | Sell | Executive/Senior Manager | -3,000 | 0.0002% | ||
| 7/1/26 | Sell | Chief Executive Officer | -15,000 | 0.0012% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.48% | +3.43% | +24.08% | +71.67% | 167B | |
| +0.85% | -0.80% | +52.79% | +161.33% | 1,051B | |
| +1.23% | -1.53% | +54.58% | +59.08% | 609B | |
| +0.04% | +2.58% | +34.47% | +86.33% | 450B | |
| +0.78% | -0.71% | +29.28% | +24.10% | 330B | |
| +1.41% | +0.58% | +35.44% | +40.67% | 284B | |
| -0.27% | -1.87% | +22.34% | +22.51% | 263B | |
| -1.76% | +2.37% | -20.43% | -38.00% | 223B | |
| -1.42% | +0.80% | +24.27% | +57.50% | 198B | |
| -0.36% | +3.64% | +2.37% | -30.88% | 143B | |
| Average | -0.10% | +0.85% | +25.92% | +45.43% | 371.78B | |
| Weighted average by Cap. | +0.34% | +0.16% | +36.16% | +75.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.47B 26.66B 24.63B 22.67B 42.72B 2,933B 43.7B 294B 115B 1,434B 114B 112B 4,951B | 32.4B 28.35B 26.19B 24.1B 45.43B 3,119B 46.47B 312B 123B 1,525B 122B 119B 5,265B |
| Net income | -3.39B -2.97B -2.74B -2.52B -4.75B -326B -4.86B -32.68B -12.85B -160B -12.73B -12.45B -551B | 9.76B 8.54B 7.89B 7.26B 13.69B 940B 14B 94.07B 37B 459B 36.66B 35.85B 1,586B |
| Net Debt | 9.46B 8.28B 7.65B 7.04B 13.26B 911B 13.57B 91.16B 35.86B 445B 35.52B 34.74B 1,537B | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | $134.28 | -1.48% | 6,903,235 |
| 26-07-16 | $136.30 | +3.49% | 7,926,819 |
| 26-07-15 | $131.70 | +1.28% | 4,467,637 |
| 26-07-14 | $130.04 | -1.04% | 5,255,960 |
| 26-07-13 | $131.40 | +1.21% | 5,131,594 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions
